Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1959 Dec;38(12):2101–2110. doi: 10.1172/JCI103988

INHIBITION OF ALDOSTERONE SECRETION AND MODIFICATION OF ELECTROLYTE EXCRETION IN MAN BY A CHEMICAL INHIBITOR OF 11β-HYDROXYLATION*,

William S Coppage Jr 1, Donald Island 1, Maureen Smith 1, Grant W Liddle 1
PMCID: PMC293300  PMID: 13811859

Full text

PDF
2102

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTTER F. C., DUNCAN L. E., Jr, LIDDLE G. W. Dual mechanism regulating adrenocortical function in man. Am J Med. 1956 Sep;21(3):380–386. doi: 10.1016/0002-9343(56)90038-9. [DOI] [PubMed] [Google Scholar]
  2. BONGIOVANNI A. M., EBERLEIN W. R. Plasma and urinary corticosteroids in the hypertensive form of congenital adrenal hyperplasia. J Biol Chem. 1956 Nov;223(1):85–94. [PubMed] [Google Scholar]
  3. CHART J. J., SHEPPARD H., ALLEN M. J., BENCZE W. L., GAUNT R. New amphenone analogs as adrenocortical inhibitors. Experientia. 1958 Apr 15;14(4):151–152. doi: 10.1007/BF02157133. [DOI] [PubMed] [Google Scholar]
  4. Callow N. H., Callow R. K., Emmens C. W. Colorimetric determination of substances containing the grouping -CH(2).CO- in urine extracts as an indication of androgen content. Biochem J. 1938 Aug;32(8):1312–1331. doi: 10.1042/bj0321312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DREKTER I. J., HEISLER A., SCISM G. R., STERN S., PEARSON S., McGAVACK T. H. The determination of urinary steroids. I. The preparation of pigment-free extracts and a simplified procedure for the estimation of total 17-ketosteroids. J Clin Endocrinol Metab. 1952 Jan;12(1):55–65. doi: 10.1210/jcem-12-1-55. [DOI] [PubMed] [Google Scholar]
  6. JENKINS J. S., MEAKIN J. W., NELSON D. H., THORN G. W. Inhibition of adrenal steroid 11-oxygenation in the dog. Science. 1958 Aug 29;128(3322):478–480. doi: 10.1126/science.128.3322.478-a. [DOI] [PubMed] [Google Scholar]
  7. LIDDLE G. W. Aldosterone antagonists. AMA Arch Intern Med. 1958 Dec;102(6):998–1004. doi: 10.1001/archinte.1958.00260230144018. [DOI] [PubMed] [Google Scholar]
  8. LIDDLE G. W., ISLAND D., LANCE E. M., HARRIS A. P. Alterations of adrenal steroid patterns in man resulting from treatment with a chemical inhibitor of 11 beta-hydroxylation. J Clin Endocrinol Metab. 1958 Aug;18(8):906–912. doi: 10.1210/jcem-18-8-906. [DOI] [PubMed] [Google Scholar]
  9. SANDERSON P. H. Potentiometric determination of chloride in biological fluids. Biochem J. 1952 Nov;52(3):502–505. doi: 10.1042/bj0520502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. SILBER R. H., PORTER C. C. The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma. J Biol Chem. 1954 Oct;210(2):923–932. [PubMed] [Google Scholar]
  11. ULICK S., LARAGH J. H., LIEBERMAN S. The isolation of a urinary metabolite of aldosterone and its use to measure the rate of secretion of aldosterone by the adrenal cortex of man. Trans Assoc Am Physicians. 1958;71:225–235. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES